| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -1.54% | +9.57% | +55.61% | +158.64% | 1,097B | |
| -0.80% | +7.24% | +67.85% | +54.90% | 622B | |
| -0.88% | +7.45% | +35.90% | +87.23% | 449B | |
| -1.62% | +6.34% | +29.51% | +24.01% | 334B | |
| -1.38% | +3.75% | +39.33% | +25.04% | 294B | |
| +0.30% | +2.56% | +31.62% | +40.64% | 286B | |
| -0.10% | +2.23% | -28.43% | -42.77% | 213B | |
| +0.28% | +4.11% | +29.39% | +62.72% | 195B | |
| +0.04% | +0.96% | +13.87% | +63.81% | 157B | |
| Average | -0.50% | +6.79% | +30.52% | +52.69% | 405.19B | |
| Weighted average by Cap. | -0.89% | +8.72% | +41.58% | +78.82% |
Employees
4
Sector
Pharmaceuticals
